Jason Chamberlain

Jason Chamberlain is currently serving as Vice President and Head of Nonclinical Development at Roivant Sciences since August 2022. With extensive experience in the biopharmaceutical industry, Jason previously held the position of Senior Director at Horizon from July 2018 to August 2022 and Associate Director at Gilead Sciences from January 2011 to July 2018. Additional experience includes roles as Associate Director of Bioanalytical and Preclinical Development at Arresto BioSciences, Study Director at SNBL USA and Charles River Laboratories, and Research Associate at VA Medical Center. Jason Chamberlain holds a PhD in Cell & Molecular Biology with a focus on Stem Cell Transplantation, an MBA, and a BS in Biochemistry from the University of Nevada, Reno.